Sensyne Health 주식 주식분석 | 주식가격 | 뉴스 | SENS.L | GB00BYV3J755 | A2N38D

날짜	Sensyne Health 주식 가격
	0.00 undefined
	0.01 undefined

날짜	Sensyne Health 매출	Sensyne Health EBIT	Sensyne Health 이익
2026e	143.63 백만 undefined	76.92 백만 undefined	756.09 undefined
2025e	114 백만 undefined	43.25 백만 undefined	1,360.19 undefined
2024e	75.76 백만 undefined	24.56 백만 undefined	2,471.43 undefined
2023e	54.06 백만 undefined	10.02 백만 undefined	100,471.27 undefined
2022e	27.24 백만 undefined	-9.07 백만 undefined	-92,418.1 undefined
2021	9.1 백만 undefined	-26.91 백만 undefined	-27.52 백만 undefined
2020	2.05 백만 undefined	-21.04 백만 undefined	-21.84 백만 undefined
2019	140,000 undefined	-15.67 백만 undefined	-21.93 백만 undefined
2018	80,000 undefined	-7.25 백만 undefined	-49.84 백만 undefined

	매출	EBIT	이익
2018	80,000 GBP	-7.25 백만 GBP	-49.84 백만 GBP
2019	140,000 GBP	-15.67 백만 GBP	-21.93 백만 GBP
2020	2.05 백만 GBP	-21.04 백만 GBP	-21.84 백만 GBP
2021	9.1 백만 GBP	-26.91 백만 GBP	-27.52 백만 GBP
2022e	27.24 백만 GBP	-9.07 백만 GBP	-92,418.1 GBP
2023e	54.06 백만 GBP	10.02 백만 GBP	100,471.27 GBP
2024e	75.76 백만 GBP	24.56 백만 GBP	2,471.43 GBP
2025e	114 백만 GBP	43.25 백만 GBP	1,360.19 GBP
2026e	143.63 백만 GBP	76.92 백만 GBP	756.09 GBP

2018	2019	2020	2021	2022e	2023e	2024e	2025e	2026e
0	0	2	9	27	54	75	114	143
-	-	-	350.00	200.00	100.00	38.89	52.00	25.44
-	-	50.00	55.56	-	-	-	-	-
0	0	1	5	0	0	0	0	0
-7	-15	-21	-26	-9	10	24	43	76
-	-	-1,050.00	-288.89	-33.33	18.52	32.00	37.72	53.15
-49	-21	-21	-27	0	0	0	0	0
-	-57.14	-	28.57	-	-	-	-	-
94.78	119.02	129.24	139.22	0	0	0	0	0
-	-	-	-	-	-	-	-	-

2018	2019	2020	2021

4.54	49.25	31.66	23.57
0.04	0.07	1.04	5.41
0.19	0.54	2.09	1.66
0	0	0	0
4.15	0.38	0.74	1.08
8.92	50.24	35.53	31.72
0.1	2.48	3.04	2.49
0.11	0	0.47	2.32
0	0	0	0
4.71	18.07	14.9	25.45
0	0	0	0
0	0	0	0
4.92	20.55	18.41	30.26
13.84	70.79	53.94	61.98

109.9	12.86	12.86	16.48
0	59.48	59.48	91.36
-27.84	-6.91	-28.51	-55.19
-69,850	-20	30	90
0	0	0	0
12.21	65.41	43.86	52.74
0.42	1.2	4.07	3.15
0.76	1.66	2.99	3.77
450	500	870	260
0	0	0	0
0	240	390	390
1.63	3.6	8.32	7.57
0	1.77	1.72	1.65
0	0	0	0
0	0	30	40
0	1.77	1.75	1.69
1.63	5.37	10.07	9.26
13.84	70.78	53.93	62

2018	2019	2020	2021
-7	-18	-22	-28
1	3	4	5
0	0	0	0
0	1,000	1,000	-3,000
-2,000	0	1,000	1,000
0	0	0	0
0	0	0	0
-8	-14	-14	-25
0	-2	-2	-5
0	-2	-2	-8
0	0	0	-2
0	0	0	0
0	0	0	0
10	64	0	27
10	61	0	25
-	-2.00	-	-1.00
0	0	0	0
1	44	-17	-8
0	0	0	0
0	0	0	0

Sensyne Health 브루토마진	Sensyne Health 이익 마진	Sensyne Health EBIT-마진	Sensyne Health 이익 마진
2026e	64.95 %	53.56 %	0 %
2025e	64.95 %	37.94 %	0 %
2024e	64.95 %	32.42 %	0 %
2023e	64.95 %	18.53 %	0.19 %
2022e	64.95 %	-33.29 %	-0.34 %
2021	64.95 %	-295.71 %	-302.42 %
2020	56.59 %	-1,026.34 %	-1,065.37 %
2019	-28.57 %	-11,192.86 %	-15,664.29 %
2018	-137.5 %	-9,062.5 %	-62,300 %

	브루토마진	EBIT-마진	이익 마진
2018	-137.5 %	-9,062.5 %	-62,300 %
2019	-28.57 %	-11,192.86 %	-15,664.29 %
2020	56.59 %	-1,026.34 %	-1,065.37 %
2021	64.95 %	-295.71 %	-302.42 %
2022e	64.95 %	-33.29 %	-0.34 %
2023e	64.95 %	18.53 %	0.19 %
2024e	64.95 %	32.42 %	0 %
2025e	64.95 %	37.94 %	0 %
2026e	64.95 %	53.56 %	0 %

날짜	Sensyne Health 주당 매출	Sensyne Health EBIT 당 주식	Sensyne Health 주당 이익
2026e	0.86 undefined	0 undefined	0 undefined
2025e	0.68 undefined	0 undefined	0 undefined
2024e	0.46 undefined	0 undefined	0 undefined
2023e	0.32 undefined	0 undefined	0 undefined
2022e	0.16 undefined	0 undefined	-0 undefined
2021	0.07 undefined	-0.19 undefined	-0.2 undefined
2020	0.02 undefined	-0.16 undefined	-0.17 undefined
2019	0 undefined	-0.13 undefined	-0.18 undefined
2018	0 undefined	-0.08 undefined	-0.53 undefined

	주당 매출	EBIT 당 주식	주당 이익
2018	0 GBP	-0.08 GBP	-0.53 GBP
2019	0 GBP	-0.13 GBP	-0.18 GBP
2020	0.02 GBP	-0.16 GBP	-0.17 GBP
2021	0.07 GBP	-0.19 GBP	-0.2 GBP
2022e	0.16 GBP	0 GBP	-0 GBP
2023e	0.32 GBP	0 GBP	0 GBP
2024e	0.46 GBP	0 GBP	0 GBP
2025e	0.68 GBP	0 GBP	0 GBP
2026e	0.86 GBP	0 GBP	0 GBP

	주식 수량
2018	94.78 백만 Aktien
2019	119.02 백만 Aktien
2020	129.24 백만 Aktien
2021	139.22 백만 Aktien
2022e	139.22 백만 Aktien
2023e	139.22 백만 Aktien
2024e	139.22 백만 Aktien
2025e	139.22 백만 Aktien
2026e	139.22 백만 Aktien

%-지분	이름	주식	변경
24.38698 %	Lord Paul Radd Drayson	40,594,574	20,713,412
10.76815 %	Lady Elspeth Drayson	17,924,656	480,087
8.07208 %	Lansdowne Partners (UK) LLP	13,436,786	0
6.62299 %	Sand Grove Capital Management LLP	11,024,633	6,476,909
4.34437 %	Gatemore Capital Management LLP	7,231,642	0
3.39200 %	Oxford University Hospitals NHS Foundation Trust	5,646,325	43,155
2.06960 %	South Warwickshire NHS Foundation Trust	3,445,050	0
2.06960 %	Chelsea and Westminster Hospital NHS Foundation Trust	3,445,050	0
1.38542 %	Schroder Investment Management Ltd. (SIM)	2,306,172	0
1.32240 %	University of Oxford	2,201,275	2,201,275
1.29010 %	Jefferies GmbH	2,147,495	5,158
1.26156 %	St. Petri Capital	2,100,000	2,100,000
1.11769 %	Patel (Paresh Praful)	1,860,499	1,860,499
0.92811 %	Bellhouse (Elisabeth)	1,544,932	0
0.85821 %	Milton Keynes University Hospital NHS Foundation Trust	1,428,571	1,428,571
0.85821 %	Somerset NHS Foundation Trust	1,428,571	1,428,571
0.85821 %	Royal Wolverhampton NHS Trust Ltd	1,428,571	1,428,571
0.85821 %	Hampshire Hospitals NHS Foundation Trust	1,428,571	1,428,571
0.84511 %	Invesco Advisers, Inc.	1,406,768	-6,219,612
0.60074 %	AXA Investment Managers Paris	1,000,000	0
0.43628 %	Artemis Investment Management LLP	726,233	0
0.38389 %	Tenax Capital Ltd.	639,017	-323,748
0.35750 %	Janus Henderson Investors	595,093	-328,207
0.35494 %	Rangel (Manuel Pinuela)	590,839	-301,446
0.28191 %	Saul (Gordon M)	469,265	0
0.24788 %	Fondo De Energia Ilimitada S.A.P.I. De CV	412,626	0
0.21584 %	Bell (John Irving)	359,289	359,289
0.18712 %	Rayfield (Margaret)	311,473	0
0.15169 %	Aberdeen Standard Investments (Edinburgh)	252,500	118,233
0.15019 %	Elman (Andrew Mark)	250,000	250,000
0.12742 %	Dau Herrera (Jose Elias)	212,098	0
0.11795 %	Bishop (Hugh Richard)	196,347	0
0.11461 %	Bellhouse (Mary)	190,776	0
0.11303 %	Edmonds (Henry Harry)	188,154	0
0.09675 %	Grobler (Nicholas John)	161,052	0
0.09067 %	Drayson (Guy)	150,925	0
0.08971 %	Curtis (Catherine)	149,332	0
0.08350 %	Credit Suisse Asset Management	139,000	87,000
0.08104 %	Avignone (Gianpaolo)	134,897	0
0.07185 %	Corporation of Lloyds	119,600	-102,036
0.07180 %	Bellhouse (Thomas)	119,518	0
0.07030 %	Sarphie (Anna)	117,029	0
0.06946 %	Bhaduri (Shiv Shankar)	115,624	0
0.06545 %	O'Rourke (Kate)	108,943	0
0.06460 %	Bellhouse (Emily)	107,536	0
0.06113 %	Zepeda (Holda Maria Puron)	101,750	101,750
0.05652 %	Som.Us Intermediaro De Reaseguro S.A. De C.V.	94,077	0
0.05407 %	Close Brothers Asset Management	90,000	0
0.04666 %	Gallagher (Michael K)	77,667	0
0.04631 %	Grant (Robert)	77,083	0
0.04385 %	Gilbert (Joanne)	73,001	0
0.03851 %	Patel (Nita)	64,110	0
0.03851 %	Patel (Himesh)	64,110	0
0.03596 %	Edmonds (Zoreh)	59,854	0
0.03572 %	Jones (Oliver)	59,454	0
0.03350 %	Daly (Jonathan)	55,757	0
0.03304 %	Barlow (Johanna)	55,000	0
0.03116 %	Gonet & Cie SA	51,872	0
0.02952 %	Bradwell (Susan Jayne)	49,141	0
0.02653 %	Bradwell (Julian)	44,170	0
0.02472 %	Patel (Nimisha Ambala)	41,145	0
0.02472 %	Patel (Minesh)	41,145	0
0.02403 %	Morley (Jennifer Mary)	40,000	40,000
0.02389 %	Rangel (Enrique Pinuela)	39,761	0
0.02347 %	Puron (Antonio)	39,075	0
0.02315 %	Teixeira (Raul)	38,542	0
0.02315 %	Hawkes (Steven)	38,542	0
0.02238 %	Cowie (Natalie)	37,259	0
0.02166 %	Simpson (Ian)	36,051	0
0.02085 %	Drayson (Michael)	34,705	0
0.02002 %	Stephenson (Christopher)	33,333	0
0.01976 %	Patel (Jaymin)	32,895	0
0.01976 %	Patel (Poonam)	32,895	0
0.01958 %	Gibb (Darren)	32,600	0
0.01914 %	Gill (Andrew)	31,861	0
0.01862 %	Sanderson (Phillip Lindsey)	31,000	0
0.01861 %	Armstrong (Alistair)	30,979	0
0.01713 %	Romano (Adam)	28,521	0
0.01713 %	Haidinger Ramos (Karen)	28,521	0
0.01669 %	Norris (Michael John)	27,777	0
0.01659 %	Angistalis (Konstantinos)	27,624	-10,918
0.01621 %	Onoigboria (Aizehi)	26,979	0
0.01621 %	Albert (Jimena)	26,979	0
0.01496 %	Cooke (Joanne Lesley)	24,898	0
0.01496 %	Cooke (Stuart)	24,898	0
0.01335 %	Tarassenko (Lionel)	22,222	0
0.01335 %	Gulati (Vishal)	22,222	0
0.01335 %	Hardy (Mary)	22,222	0
0.01001 %	Macdonnell (Michael)	16,666	16,666
0.00667 %	Keogh (Bruce)	11,111	0
0.00334 %	Hillier (Laura)	5,555	5,555
0.00334 %	Ram (Nick Scott)	5,555	5,555
0 %	Amati Global Investors Limited	0	-7,084,847
0 %	Neuberger Berman, LLC	0	-8,002
0 %	Canaccord Genuity Wealth Management	0	-6,046,000
0 %	Octopus Investments Limited	0	-1,648,750
0 %	Church House Investments Limited	0	-450,000
0 %	Lupus alpha Asset Management AG	0	-1,900,000
0 %	Blackford (Stephen James)	0	-39,000
0 %	Mackenzie Investments Europe Limited	0	-1,382,194

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Microsoft	공급업체고객	0,25	0,66	0,48	0,89	-0,21	-0,10
Cognizant Tech A	공급업체고객	-0,29	0,65	0,52	-0,45	-0,85	-0,12
Evotec	공급업체고객	-0,37	0,70	0,55	0,91	0,75	0,46
Bristol-Myers Squibb	공급업체고객	-0,40	0,37	-0,86	-0,86	-0,42	-0,20
Bayer	공급업체고객	-0,52	0,22	-0,79	-0,79	-0,67	-0,49
Alexion Pharmaceuticals, Inc.	공급업체고객	-0,77	-0,47	-0,87	-0,83	-0,90
Roche Holding	공급업체고객	-0,85	0,69	-0,44	0,28	-0,30	-0,42

What values and corporate philosophy does Sensyne Health represent?

Sensyne Health PLC is a leading healthcare technology company that focuses on improving patient outcomes. The company values innovation, collaboration, and ethical behavior in its pursuit of transforming healthcare through the use of artificial intelligence and clinical data analysis. Sensyne Health PLC strongly believes in the responsible and transparent use of patient data to drive breakthrough discoveries and enhance medical research. By partnering with the NHS and other healthcare organizations, Sensyne Health PLC aims to create value for patients, clinicians, and shareholders alike. With its commitment to putting patients at the center of its work, Sensyne Health PLC is dedicated to revolutionizing healthcare delivery for the benefit of all.

In which countries and regions is Sensyne Health primarily present?

Sensyne Health PLC is primarily present in the United Kingdom (UK). As a leading digital health technology company, Sensyne Health operates in various regions within the UK, including England, Scotland, Wales, and Northern Ireland. With its headquarters in Oxford, Sensyne Health focuses on delivering innovative solutions to drive improvements in patient care and health outcomes. By leveraging advanced analytics, artificial intelligence, and clinical expertise, Sensyne Health aims to transform the way healthcare is delivered and managed.

What significant milestones has the company Sensyne Health achieved?

Sensyne Health PLC, a prominent healthcare technology and artificial intelligence company, has achieved remarkable milestones throughout its journey. The company successfully secured a listing on the London Stock Exchange's Main Market in 2018. Moreover, it has entered into strategic collaborations with prestigious institutions like the University of Oxford and the South Warwickshire NHS Foundation Trust, bolstering its position in the healthcare industry. Sensyne Health has also gained recognition for its innovative data-driven solutions, focusing on improving patient outcomes and advancing precision medicine through machine learning algorithms. With an impressive track record, Sensyne Health PLC continues to make significant strides in transforming the healthcare landscape.

What is the history and background of the company Sensyne Health?

Sensyne Health PLC is a renowned healthcare technology company based in the United Kingdom. Established in 2018, the company specializes in the ethical application of clinical artificial intelligence to improve patient care and support medical research. Sensyne Health PLC collaborates with NHS Trusts and other healthcare organizations to develop secure, scalable, and regulatory-compliant digital health solutions. With a strong focus on data analysis, the company aims to harness the power of technology to enhance healthcare outcomes and expedite medical discoveries. Sensyne Health PLC continually strives to revolutionize the healthcare industry through innovation and transformative solutions.

Who are the main competitors of Sensyne Health in the market?

The main competitors of Sensyne Health PLC in the market are other companies operating in the digital healthcare sector, such as Cerner Corporation, Allscripts Healthcare Solutions Inc., and Teladoc Health Inc. These companies offer similar digital health solutions and technologies, competing directly with Sensyne Health in terms of product offerings and market share. Additionally, other established healthcare technology companies could also be considered as competitors, depending on the specific services they provide. However, Sensyne Health PLC maintains a unique position in the market with its proprietary artificial intelligence technology and data analysis capabilities.

In which industries is Sensyne Health primarily active?

Sensyne Health PLC primarily operates in the healthcare and technology industries.

What is the business model of Sensyne Health?

The business model of Sensyne Health PLC is focused on the development and application of artificial intelligence (AI) technology in healthcare. Sensyne Health combines clinical expertise with advanced data analytics to create new insights and solutions for the healthcare industry. By leveraging AI algorithms and machine learning, the company aims to unlock the value of patient data, enabling the discovery of novel insights and the development of innovative therapies and care pathways. Sensyne Health collaborates with patient groups, academic institutions, and healthcare providers to accelerate the development of personalized and data-driven healthcare solutions.

Sensyne Health 2024의 P/E 비율은 얼마입니까?

Sensyne Health의 P/E 비율은 197.16입니다.

Sensyne Health 2024의 KUV는 얼마입니까?

Sensyne Health의 P/S 비율은 0.01입니다.

Sensyne Health의 AlleAktien 품질 점수는 얼마인가요?

Sensyne Health에 대한 AlleAktien 품질 점수는 4/10입니다.

Sensyne Health 2024의 매출은 얼마인가요?

예상되는 Sensyne Health 매출은 75.76 백만 GBP입니다.

Sensyne Health 2024의 이익은 얼마인가요?

예상되는 Sensyne Health 이익은 2,471.43 GBP입니다.

Sensyne Health은 무엇을 하나요?

Sensyne Health PLC is a leading digital health company that offers novel clinical decision support systems and artificial intelligence solutions for healthcare providers. With a focus on improving patient care through the application of data science, Sensyne Health provides personalized medical solutions tailored to the needs of patients, providers, and health systems.